ghk cu pain ghk-cu injection sites administration route Understanding Peptide Techniques for Management GHK-Cu ghk cu long term use

DSIP Regulatory Status As of June 2026, DSIP is not FDA-approved for any human indication

Sections were placed in fluorescent secondary antibody and incubated at room temperature for 2 h, protected from light

Subdermal application overcomes this barrier and directly reaches the deeper layers of the skin, resulting in higher absorption and efficacy

Composition Active Ingredient: Human Chorionic Gonadotropin (HCG) 5,000 IU Form: Lyophilized Powder Appearance: White crystalline powder in a sealed research vial Purity: 99% (HPLC/LC-MS Verified) Packaging: Tamper-evident vial with lot number and testing information Research Applications (Non-Clinical) Gonadotropin receptor pathway characterization Endocrine signaling and receptor-binding studies Analytical method development and validation Compound identity verification through HPLC/LC-MS analysis Quantitative assay calibration and optimization Stability evaluation of lyophilized peptide materials Laboratory research involving hormonal signaling mechanisms Documentation & Traceability MNM Compounds is committed to providing comprehensive documentation and quality assurance for every research compound offered